Studies based on double-mutant engineered melanoma cells containing NRAS and BRAF activating mutations showed that the expression of the two genetic alterations can induce cell senescence because of an overactivation of the RAS/RAF/ERK pathway (41). The gene discussed is BRAF; the disease is melanoma.